Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

Vast Majority of HFrEF Patients Eligible for Vericiguat

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

February 08, 2023

Even When Eligible, Not All Acute HF Patients Get GDMT

News Daily News

Even When Eligible, Not All Acute HF Patients Get GDMT

January 11, 2023

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

TCTMD’s Top 10 Most Popular Stories for September 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

October 01, 2021

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

May 27, 2021

FDA Approves Vericiguat for High-risk Patients With HF

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

November 20, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.